1. Home
  2. QH vs FEMY Comparison

QH vs FEMY Comparison

Compare QH & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

QH

Quhuo Limited American Depository Shares

SELL

Current Price

$4.62

Market Cap

14.8M

ML Signal

SELL

Logo Femasys Inc.

FEMY

Femasys Inc.

HOLD

Current Price

$2.22

Market Cap

12.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QH
FEMY
Founded
2012
2004
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.8M
12.0M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
QH
FEMY
Price
$4.62
$2.22
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.50
AVG Volume (30 Days)
26.1K
143.8K
Earning Date
04-02-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
44.71
EPS
N/A
N/A
Revenue
N/A
$2,293,313.00
Revenue This Year
N/A
$105.16
Revenue Next Year
N/A
$200.23
P/E Ratio
$2.86
N/A
Revenue Growth
N/A
40.77
52 Week Low
$0.06
$0.29
52 Week High
$12.81
$6.29

Technical Indicators

Market Signals
Indicator
QH
FEMY
Relative Strength Index (RSI) 45.63 34.61
Support Level $3.90 $0.41
Resistance Level $5.40 $3.21
Average True Range (ATR) 0.49 0.28
MACD 0.02 -0.07
Stochastic Oscillator 40.67 15.80

Price Performance

Historical Comparison
QH
FEMY

About QH Quhuo Limited American Depository Shares

Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services. It generates maximum of its revenue from the on-demand delivery solutions segment.

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: